Amr El Meligy, M.D.
Cardiovascular Disease Physician in Keene, New Hampshire.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,810 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Amr El Meligy, M.D. reported a CMS MIPS final score of 76/100 - below the 83.5 national average - and filed 2,234 Medicare Part D claims in 2023.
- 76/100
- MIPS score · -7 vs avg
- 2K
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1538543756 · Cardiovascular Disease Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1538543756
- ENUM-MID 2015
- TAX-MID 25K Cardiovascular Disease
- MIPS-BELOW 76/100
- RX-MID 2,234
- BOOK-THIN 137 in New Hampshire
- PHOTO-FINISH Robert Schnitzler · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- El Meligy · this…
El Meligy · this provider
76 MIPS pts
- Robert Schnitzle…
Robert Schnitzler
76 MIPS pts
- Donald McSweyn ·…
Donald McSweyn
76 MIPS pts
- Douglas Kosmicki…
Douglas Kosmicki
76.1 MIPS pts
- Tarun Nagrani · …
Tarun Nagrani
76.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Amr El Meligy, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Amr El Meligy, M.D. sits
This provider among cardiovascular disease physician peers
Across the 7,999 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Amr El Meligy, M.D. writes more Part D claims than 43% of them and scores higher on MIPS quality than 16% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Amr El Meligy, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Amr El Meligy, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amr El Meligy, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Hampshire
How Cardiovascular Disease Physician compares to other specialties among New Hampshire providers
Cardiovascular Disease Physician ranks #48 among New Hampshire's specialties (0.4% of in-state providers)
Each bar is a specialty's share of the New Hampshire provider total, by primary NUCC taxonomy. The highlighted bar is Cardiovascular Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Amr El Meligy, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 76/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Cardiovascular Disease Physician US NPIs
76/100 MIPS final score - 7.5 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician. Quality dim: 65.3. Cost dim: 54.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1538543756 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/17/2015 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Amr El Meligy, M.D.'s current license status, disciplinary history, and board certifications with the New Hampshire Board of Medicine in New Hampshire before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1538543756 is the unique 10-digit identifier CMS uses to link El Meligy across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Amr El Meligy, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 2,234 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,937
- Total Day Supply
- 143,595
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $176K
- Generic Drug Cost
- $35K
Patient Demographics
- Average Patient Age
- 73.9 years
- Avg HCC Risk Score
- 1.35
- Gender Split
- 45% female / 55% male
- Age Distribution
- <65: 38, 65-74: 218, 75-84: 147, 85+: 54
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amr El Meligy, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metoprolol Succinate
Metoprolol Succinate
325 claims
- Atorvastatin Calcium
Atorvastatin Calcium
311 claims
- Eliquis
Eliquis
167 claims
- Furosemide
Furosemide
148 claims
- Spironolactone
Spironolactone
139 claims
- Losartan Potassium 119
Losartan Potassium
119 claims
- Metoprolol Tartrate 96
Metoprolol Tartrate
96 claims
- Amlodipine Besylate 93
Amlodipine Besylate
93 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 325 |
| Atorvastatin Calcium | 311 |
| Eliquis Apixaban | 167 |
| Furosemide | 148 |
| Spironolactone | 139 |
| Losartan Potassium | 119 |
| Metoprolol Tartrate | 96 |
| Amlodipine Besylate | 93 |
| Lisinopril | 74 |
| Rosuvastatin Calcium | 66 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Amr El Meligy, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
Amr El Meligy, M.D.'s 2,234 claims are below the specialty average of 3,033.
Nationwide Cardiovascular Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for El Meligy, both outside New Hampshire so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (76 here).
Same NPPES enumeration year (2015)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Cardiovascular Disease Physician Providers in New Hampshire
Other clinicians with the same primary specialty enrolled in New Hampshire, drawn from the same CMS NPPES roster as El Meligy.
One of 137 Cardiovascular Disease Physician providers enrolled in New Hampshire, 5 are shown here.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Amr El Meligy, M.D.'s specialty? ▼
How much does Amr El Meligy, M.D. prescribe under Medicare Part D? ▼
What is Amr El Meligy, M.D.'s Medicare quality score? ▼
Where is Amr El Meligy, M.D. located? ▼
What is Amr El Meligy, M.D.'s NPI number? ▼
Does Amr El Meligy, M.D. prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does Amr El Meligy, M.D. prescribe most often? ▼
Does Amr El Meligy, M.D. accept Medicare? ▼
How can I verify Amr El Meligy, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.